Section III ยท Last reviewed 2026-05-25
International rollout
How the Dutch Protocol spread through guidelines and clinics โ and how, since 2020, several countries have moved to revisions.
Summary
The Dutch Protocol was adopted internationally; according to the Cass Review the Endocrine Society guideline (2009) and WPATH SOC 7 (2012) influenced almost all other guidelines (source). From 2020 onwards, several countries โ Sweden, Finland and the United Kingdom โ have re-evaluated practice and restricted medical treatment of minors (source). For a direct overview: the comparative table.
Critical note
According to the Cass Review the Dutch approach was later extended to a broader group of adolescents who would not have met the criteria of the original Dutch study, and the current group is a different cohort from that of the earlier studies (source). Sweden (Socialstyrelsen, 2022) and Finland (2020) recommend medical treatment, given the lack of evidence, only within a research framework (Cass Review), and in March 2024 NHS England stopped routine commissioning of puberty blockers for under-18s (source). The Netherlands kept its approach: on 30 June 2026 the Gezondheidsraad saw no reason to organise care differently (source).1
Subpages
- Comparative table โ all countries in one overview
- Spread โ how the model spread internationally
- United Kingdom โ Tavistock GIDS
- Sweden โ Karolinska and SBU
- Finland โ COHERE guideline 2020
- Norway โ Ukom 2023
- Denmark
- Germany
- United States โ Endocrine Society, AAP, WPATH
- Australia
- Worldwide status 2025
- Athena Forum (EU) โ European think tank for sex-based rights
Related
- Evaluations โ overview โ the evaluation reports countries draw on.
- Guidelines international โ primary documents.
- Current status Netherlands.
- People index ยท Timeline.
- FAQ ยท Glossary
Footnotes
- Cass H. Independent review of gender identity services for children and young people: final report. NHS England; April 2024.